Growing epidemiological evidence offers an explanation that the metabolic syndrome of visceral obesity is responsible for bone loss through the secretion of pro-inflammatory cytokines and hormones, such as tumour necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β)3,4. This evidence concerns the gene IL1B and metabolic syndrome.